Identification of putative, stable binding regions through flexibility analysis of HIV-1 gp120

Proteins: Structure, Function and Bioinformatics

Volumn 74, Issue 4, 2009, Pages 881-894

  Tan, Hepan ^a   Rader, A J ^a  

^a Biology SL332   (United States)

Author keywords

Consensus rigid region; FIRST; Flexibility index; gp120 binding; Graph theory rigidity; HIV entry inhibition

Indexed keywords

CD4 ANTIGEN; GLYCOPROTEIN GP 120; NEUTRALIZING ANTIBODY; LIGAND;

ARTICLE; BETA SHEET; COMPUTER PROGRAM; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STRUCTURE; THERMODYNAMICS; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; GENETICS; HYDROGEN BOND; METABOLISM; PROTEIN CONFORMATION; STRUCTURE ACTIVITY RELATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIGENS, CD4; BINDING SITES; HIV ENVELOPE PROTEIN GP120; HIV-1; HYDROGEN BONDING; LIGANDS; MODELS, MOLECULAR; PROTEIN CONFORMATION; SOFTWARE; STRUCTURE-ACTIVITY RELATIONSHIP; THERMODYNAMICS;

EID: 61449127303     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.22196     Document Type: Article

References (39)

1. De Clercq E. Emerging anti-HIV drugs. Expert Opin Emerg Drug 2005;10:241-273.
2. D'souza MP, Cairns JS, Plaeger SF. Current evidence and future directions for targeting HIV entry: therapeutic and prophylactic strategies. JAMA 2000;284:215-222.
3. Tomkowicz B, Collman RG. HIV-1 entry inhibitors: closing the front door. Expert Opin Therap Targ 2004;8:65-78.
4. Chantry D. HIV entry and fusion inhibitors. Expert Opin Emerg Drugs 2004;9:1-7.
5. Reeves JD, Piefer AJ. Emerging drug targets for antiretroviral therapy. Drugs 2005;65:1747-1766.
6. Sattentau QJ, Moore JP. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding. J Exp Med 1991;174:407-415.
7. Wyatt R, Sodroski J. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 1998;280:1884-1888.
8. Thali M, Moore JP, Furman C, Charles M, Ho DD, Robinson J, Sodroski J. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol 1993;67:3978-3988.
9. Trkola A, Dragic T, Arthos J, Binley JM, Olson WC, Allaway GP, Cheng-Mayer C, Robinson J, Maddon PJ, Moore JP. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 1996;384:184-187.
10. Berger EA, Murphy PM, Farber JM. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu Rev Immunol 1999;17:657-700.
11. Chan DC, Kim PS. HIV entry and its inhibition. Cell 1998;93:681-684.
12. Greenberg M, Cammack N, Salgo M, Smiley L. HIV fusion and its inhibition in antiretroviral therapy. Rev Med Virol 2004;14:321-337.
13. Kwong PD, Wyatt R, Robinson J, Sweet RW, Sodroski J, Hendrickson WA. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 1998;393:648-659.
14. Myszka DG, Sweet RW, Hensley P, Brigham-Burke M, Kwong PD, Hendrickson WA, Wyatt R, Sodroski J, Doyle ML. Energetics of the HIV gp120-CD4 binding reaction. Proc Natl Acad Sci USA 2000;97:9026-9031.
15. Balzarini J. Carbohydrate-binding agents: a potential future cornerstone for the chemotherapy of enveloped viruses? Antiviral Chem Chemother 2007;18:1-11.
16. Sirois S, Sing T, Chou KC. HIV-1 gp120 V3 loop for structure-based drug design. Curr Prot Pep Sci 2005;6:413-422.
17. Vita C, Drakopoulou E, Vizzavona J, Rochette S, Martin L, Menez A, Roumestand C, Yang YS, Ylisastigui L, Benjouad A, Gluckman JC. Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein. Proc Natl Acad Sci USA 1999;96:13091-13096.
18. Martin L, Stricher F, Misse D, Sironi F, Pugniere M, Barthe P, Prado-Gotor R, Freulon I, Magne X, Roumestand C, Menez A, Lusso P, Veas F, Vita C. Rational design of a CD4 mimic that inhibits HIV-1 entry and exposes cryptic neutralization epitopes. Nature Biotech 2003;21:71-76.
19. Huang CC, Stricher F, Martin L, Decker JM, Majeed S, Barthe P, Hendrickson WA, Robinson J, Roumestand C, Sodroski J, Wyatt R, Shaw GM, Vita C, Kwong PD. Scorpion-toxin mimics of CD4 in complex with human immunodeficiency virus gp120 crystal structures, molecular mimicry, and neutralization breadth. Structure 2005;13:755-768.
20. Jacobs DJ, Rader AJ, Kuhn LA, Thorpe MF. Protein flexibility predictions using graph theory. Proteins 2001;44:150-165.
21. Wang Y, Rader AJ, Bahar I, Jernigan RL. Global ribosome motions revealed with elastic network model. J Struct Biol 2004;147:302-314.
22. Hemberg M, Yaliraki SN, Barahona M. Stochastic kinetics of viral capsid assembly based on detailed protein structures. Biophys J 2006;90:3029-3042.
23. Rader AJ, Anderson G, Isin B, Khorana HG, Bahar I, Klein-Seetharaman J. Identification of core amino acids stabilizing rhodopsin. Proc Natl Acad Sci USA 2004;101:7246-7251.
24. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Res 2000;28:235-242.
25. Rader AJ, Hespenheide BM, Kuhn LA, Thorpe MF. Protein unfolding: rigidity lost. Proc Natl Acad Sci USA 2002;99:3540-3545.
26. Jacobs DJ, Dallakyan S, Wood GG, Heckathorne A. Network rigidity at finite temperature: relationships between thermodynamic stability, the nonadditivity of entropy, and cooperativity in molecular systems. Phys Rev 2003;68:061109.
27. Livesay DR, Dallakyan S, Wood GG, Jacobs DJ. A flexible approach for understanding protein stability. FEBS Lett 2004;576:468-476.
28. Jacobs DJ, Dallakyan S. Elucidating protein thermodynamics from the three-dimensional structure of the native state using network rigidity. Biophys J 2005;88:903-915.
29. Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, Wang X, Murray LW, Arendall WB, Snoeyink J, Richardson JS, Richardson DC. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res 2007;35:W375-W383.
30. Kwong PD, Wyatt R, Sattentau QJ, Sodroski J, Hendrickson WA. Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus. J Virol 2000;74:1961-1972.
31. Andrianov AM, Veresov VG. Structural analysis of the HIV-1 gp120 V3 loop: application to the HIV-Haiti isolates. J Biomol Struct Dyn 2007;24:597-608.
32. Zhou T, Xu L, Dey B, Hessell AJ, Van Ryk D, Xiang SH, Yang X, Zhang MY, Zwick MB, Arthos J, Burton DR, Dimitrov DS, Sodroski J, Wyatt R, Nabel GJ, Kwong PD. Structural definition of a conserved neutralization epitope on HIV-1 gp120. Nature 2007;445:732-737.
33. Jacobs DJ, Livesay DR, Hules J, Tasayco ML. Elucidating quantitative stability/flexibility relationships within thioredoxin and its fragments using a distance constraint model. J Mol Biol 2006;358:882-904.
34. Chen B, Vogan EM, Gong H, Skehel JJ, Wiley DC, Harrison SC. Structure of an unliganded simian immunodeficiency virus gp120 core. Nature 2005;433:834-841.
35. Kwong PD, Doyle ML, Casper DJ, Cicala C, Leavitt SA, Majeed S, Steenbeke TD, Venturi M, Chaiken I, Fung M, Katinger H, Parren PW, Robinson J, Van Ryk D, Wang L, Burton DR, Freire E, Wyatt R, Sodroski J, Hendrickson WA, Arthos J. HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. Nature 2002;420:678-682.
36. Rong R, Gnanakaran S, Decker JM, Bibollet-Ruche F, Taylor J, Sfakianos JN, Mokili JL, Muldoon M, Mulenga J, Allen S, Hahn BH, Shaw GM, Blackwell JL, Korber BT, Hunter E, Derdeyn CA. Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. J Virol 2007;81:5658-5668.
37. Lee WR, Syu WJ, Du B, Matsuda M, Tan S, Wolf A, Essex M, Lee TH. Nonrandom distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1992;89:2213-2217.
38. Huang CC, Tang M, Zhang MY, Majeed S, Montabana E, Stanfield RL, Dimitrov DS, Korber B, Sodroski J, Wilson IA, Wyatt R, Kwong PD. Structure of a V3-containing HIV-1 gp120 core. Science (New York NY) 2005;310:1025-1028.
39. DeLano WL. The PyMOL molecular graphics system. San Carlos, CA: DeLano Scientific; 2002.